Week in Review: WuXi Biologics Raises $511 Million in Hong Kong IPO

WuXi Biologics priced its Hong Kong IPO at the top of the range, raising $511 million and valuing the biologics operations of WuXi AppTec at $3 billion.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.